{rfName}
EM

Indexed in

License and use

Citations

Altmetrics

Grant support

BioMarin, Baxalta, Catalyst Biosciences, CSL, Novartis, Novo Nordisk, Pfizer, Roche, Sanofi, Spark, Unique, Consultant for: BioMarin, Baxalta, CSL Behring, Catalyst Biosciences, Novo Nordisk, Roche, Spark, Employee of: University of the Witwatersrand, Speaker Bureau of: Novo Nordisk, Pfizer, Roche, Sanofi, Takeda, WFH, ISTH, Springer

Analysis of institutional authors

Jimenez-Yuste, VAuthor

Share

Publications
>
Other

EMICIZUMAB PROPHYLAXIS IN PEOPLE WITH HAEMOPHILIA A (PWHA), AGED >= 50 YEARS, WITH COMORBIDITIES - POOLED DATA FROM FOUR PHASE 3 STUDIES (HAVEN 1, 3, 4, AND STASEY)

Publicated to:HAEMOPHILIA. 28 50-50 - 2022-02-01 28(), DOI:

Authors: Jimenez-Yuste, V; Oldenburg, J; Tzeng, E; Trzaskoma, B; Sanabria, F; Mahlangu, J

Affiliations

F Hoffmann La Roche Ltd, Basel, Switzerland - Author
Genentech Inc, San Francisco, CA 94080 USA - Author
Natl Hlth Lab Serv, Johannesburg, South Africa - Author
Univ Autonoma Madrid, Hosp Univ La Paz, Madrid, Spain - Author
Univ Klinikum Bonn, Bonn, Germany - Author
Univ Witwatersrand, Johannesburg, South Africa - Author
See more

Abstract

Keywords

BiotecnologíaCiência da computaçãoCiências biológicas iCiências biológicas iiCiências biológicas iiiEducação físicaEnfermagemFarmaciaGeneral medicineGenetics (clinical)HematologyInterdisciplinarMedicina iMedicina iiMedicina iiiMedicine (miscellaneous)OdontologíaPsicologíaSaúde coletiva

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal HAEMOPHILIA due to its progression and the good impact it has achieved in recent years, according to the agency Scopus (SJR), it has become a reference in its field. In the year of publication of the work, 2022, it was in position , thus managing to position itself as a Q1 (Primer Cuartil), in the category Medicine (Miscellaneous).

Leadership analysis of institutional authors

This work has been carried out with international collaboration, specifically with researchers from: Germany; South African Republic; Switzerland; United States of America.

There is a significant leadership presence as some of the institution’s authors appear as the first or last signer, detailed as follows: First Author (JIMENEZ YUSTE, VICTOR MANUEL) .